HIV DNA vaccine topical (Genetic Immunity)

N/A

Report date: 2022/08/29 20:00:24

Base Information

Drug NameHIV DNA vaccine topical (Genetic Immunity)
Drug Alias NameTherapeutic DNA dendritic cell vaccine for HIV infectionsDermaVir PatchLC-002
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesHungaryGermany
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenetic Immunity Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenetic Immunity IncNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A